These are starting points, not rigid rules
In contrast, we found a larger amount of evidence over 26 studies assessing depressive symptoms in populations with comorbid physical health conditions undergoing GLP-1RA treatment (Table 5)
Resisted wrist extension and grip testing reproduce pain
We extracted GLP-1 RAs (exenatide, liraglutide, dulaglutide, lixisenatide, semaglutide, tirzepatide) and DPP-4 inhibitors (linagliptin, alogliptin, saxagliptin, sitagliptin) from Q1 2013 to Q1 2024 for all AEs classified as biliary disorders (SMQ), with the drug role selecting the primary suspect drug (PS)
In the assessment of WSP analysis, all shape parameters and their 95% CI upper limits were 65 ( n = 1,494, 43.21%) and 65 years than in subgroups 1865 years with a higher ROR 025 of 4.19